Valinor and Renew Launch Partnership to Generate Largest Clinical Multi-Omics Dataset for Neurological Disease Model Development

Valinor Discovery ("Valinor") and Renew Biotechnologies ("Renew") today announced a strategic collaboration to generate the ...
European Medical Journal

AI Model Predicts Cardiac Tamponade During Ablation

A machine learning model predicted cardiac tamponade during AF ablation with high accuracy. Learn how XGBoost may improve ...
Grit Daily

How Brain Data and Machine Learning Could Transform the Aging Industry

Healthcare leaders have spent years trying to figure out how to manage the rising cost of aging, especially when it comes to ...
Yale Environment 360

A step toward clinically useful brain-behavior machine learning models

Relating brain activity to behavior is an ongoing aim of neuroimaging research as it would help scientists understand how the brain begets behavior — and perhaps open new opportunities for ...

Healthcare Predictive Analytics Market to Reach $128.2 Billion by 2033 Globally, at 24.3% CAGR: Allied Market Research

Allied Market Research published a report, titled, "Healthcare Predictive Analytics Market by Application (Clinical Analytics, Financial Analytics, Operational Analytics and Others), Component ...
Open Heart

Enhanced cardiovascular disease risk prediction using integrated machine learning models: a study from the UK Biobank cohort

Objective Cardiovascular diseases (CVD) remain the leading cause of mortality globally, necessitating early risk ...
Insurance Insider

Machine learning in insurance: Transforming risk management and customer experience

Explore how machine learning in insurance enhances risk assessment, fraud detection, and personalization. ✓ Subscribe for ...

Renew Biotechnologies: Valinor and Renew Launch Partnership to Generate Largest Clinical Multi-Omics Dataset for Neurological Disease Model Development

The partnership integrates high-resolution multi-omics data generation with predictive multimodal machine learning to support biopharma decision-making in neurology.SALT LAKE CITY, Feb. 24, ...